Other languages Redx Pharma Plc

Equities

Delayed London S.E. Other stock markets 11:46:01 2024-04-30 am EDT			5-day change	1st Jan Change
15 ^GBX	+31.58%		+22.45%	-31.82%

Apr. 19	Redx Pharma shareholders approve AIM delisting plans	AN
Apr. 19	Redx Pharma Gets Shareholder Approval for Delisting from AIM	MT

Redx Pharma shareholders approve AIM delisting plans	Apr. 19
Europe down after Easter holiday weekend	Apr. 02
Redx Pharma plummets on plans to delist from AIM	Apr. 02
FTSE 100 buoyed by UK manufacturing growth	Apr. 02
Redx Pharma to Delist from London Bourse	Apr. 02
Redx Pharma Doses First Patient in Early-stage Trial of Inflammatory Bowel Disease Treatment	Feb. 28
Redx Announces That First Participant Dosed in Phase 1 Trial of RXC008	Feb. 28
Redx Pharma clarifies not currently pursuing US listing	Feb. 14
Redx Pharma Denies Media Report of Potential US Listing	Feb. 14
Jazz Pharmaceuticals to Acquire Redx Pharma's KRAS Inhibitor Program	Feb. 07
Barratt and Smurfit Kappa bookend FTSE 100	Feb. 07
RedX Pharma to Sell Kirsten Rat Sarcoma Virus Inhibitor Program to Jazz Pharmaceuticals	Feb. 07
Redx Pharma shares skyrocket on deal to sell inhibitor program	Feb. 07
AIM WINNERS & LOSERS: Verditek falls on cash shell plans	Feb. 07
Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program	Feb. 07
EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens	Dec. 15
Earnings Flash (REDX.L) REDX PHARMA Reports FY23 Revenue GBP4.2M	Dec. 15
Redx Pharma Plc Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 15
Redx Unveils Preclinical Data from New Development Candidate, RXC009	Nov. 06
Redx Pharma plc to Present Preclinical Data on RXC009, A Selective Discoidin Domain Receptor 1 Inhibitor	23-10-30

No results for this search